Fortress Biotech (FBIO) Stock Price, News, Quotes-Moomoo

US Stock MarketDetailed Quotes

FBIO Fortress Biotech

Watchlist

1.7200
-0.0200-1.15%

Close Dec 20 16:00 ET

1.7201
+0.0001+0.01%

Post 20:01 ET

47.48MMarket Cap-0.58P/E (TTM)

Full Hours

5D
Daily
Weekly
Monthly
1Q
1Y

Trade Overview

Unit: --

Capital Trend

IntradayDayWeekMonth

No Data

News

Express News | Checkpoint Therapeutics Announces FDA Approval of Unloxcyt™ (Cosibelimab-Ipdl)
ReutersDec 13 18:15 ET
Checkpoint Therapeutics Announces FDA Approval of UNLOXCYT (Cosibelimab-ipdl)
GlobeNewswireDec 13 18:15 ET
Fortress Solutions Names Dan Lakey as Chief Revenue Officer to Drive Strategic Growth and Strengthen FortressONE Platform
PR NewswireDec 9 09:05 ET
Press Release: Fortress Acquires Infra Pipe Solutions, Leading Manufacturer of HDPE Pipes and Structures
Dow JonesNov 25 11:57 ET
A. G. P. Maintains Fortress Biotech(FBIO.US) With Buy Rating, Cuts Target Price to $4
Moomoo NewsNov 19 03:36 ET · Ratings
Fortress Biotech Price Target Lowered to $4 From $5 at Alliance Global Partners
TipRanksNov 18 10:15 ET

Comments

Jaguar8

Dec 13 18:10

🕛Watchlist MONDAY December 16. NFA. Trade the chart. Be kind… in progress

$Gorilla Technology (GRRR.US)$ PR: CEO will have interview with Red Chip Small Stock, Big Money show on Sat Dec 14. Reports on CEO on X that they have been selected from the shortlist for the $438M deal in SE Asia. Low float. $23.2M cash good for 12 months
$Checkpoint Therapeutics (CKPT.US)$ $Fortress Biotech (FBIO.US)$ FDA approval of drug for metastatic cutaneous squamous cell carcinoma. This drug is the first and only progr...

Jaguar8

Dec 13 17:49

I already gave you my initial Monday Watchlist. I’ll post the complete one Sunday.

my open positions
$Checkpoint Therapeutics (CKPT.US)$
$Gorilla Technology (GRRR.US)$ $Fortress Biotech (FBIO.US)$ $Tonix Pharmaceuticals (TNXP.US)$

Jaguar8

Dec 13 17:36

This is good for MONDAY for me. NFA

$Fortress Biotech (FBIO.US)$

Jaguar8

Dec 13 17:16

NEWS

$Fortress Biotech (FBIO.US)$
Checkpoint Therapeutics Announces FDA Approval of UNLOXCYT™ (cosibelimab-ipdl)
19 seconds ago, 3:15 PM PST
Via GlobeNewswire
CKPTFBIO
Share
WALTHAM, Mass., Dec. 13, 2024 (GLOBE NEWSWIRE) -- Checkpoint Therapeutics, Inc. ("Checkpoint") (NASDAQ:CKPT), today announced that the U.S. Food and Drug Administration ("FDA") has approved UNLOXCYT™ (cosibelimab-ipdl) for the treatment of adults with metastatic cutaneous squamous cell carcinoma ("cSCC") or locally advanced c...

DDDDDDDDDDD

Nov 29 15:44

$Fortress Biotech (FBIO.US)$ $Avenue Therapeutics (ATXI.US)$ DELIST

Heat List

Overall

No Data